Prince et al. provided convincing evidence for the existence of HNSCC CSCs through identification of unique tumorigenic properties of cells expressing CD44 surface antigen and aldehyde dehydrogenase (ALDH) activity [9]. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.